Foley Partner Courtenay Brinckerhoff was quoted in an article that appeared in The New York Times on December 17, 2010 titled “Court Backs Patents for Diagnostic Tests.” Brinckerhoff discusses a Court of Appeals for the Federal Circuit ruling which upholds that diagnostic tests used to determine whether a patient is getting the proper dose of a medicine can be patented. She states that the decision will be welcomed by those working in personalized medicine and may help improve both the clinical efficacy and cost-efficiency of therapeutic treatment.
People
Related News
27 August 2024
In the News
Samuel Goldstick Assesses Data Privacy Challenges for Automakers
Foley & Lardner LLP partner Samuel Goldstick underscored how disclosure can help automakers reduce legal risk in the Automotive Dive article, "Automakers face growing data privacy challenges, experts say."
26 August 2024
In the News
Judith Waltz Quoted on Inflation Reduction Act, Pharma Impact
Foley & Lardner LLP partner Judith Waltz is quoted in the PharmaVoice article, "Pharmas’ IRA court losses mount. They keep pursuing them."
20 August 2024
In the News
Kevin Hyde Featured in Q&A on Jacksonville Legal Market – 'The outlook is good'
Foley & Lardner LLP partner Kevin Hyde is featured in a Capital Analytics Associates Q&A on the major achievements of Foley's Jacksonville office, key trends in the legal market, and the firm's commitment to its talent and client service.